Ce
I appreciate your attention to my analysis.
I find the charts intriguing, particularly the concepts of "total destruction" and "buying in blood." Despite the short-term risks, the potential for significant gains, such as 10x, 50x, or even 100x returns in the long term, is undeniable.
Upon closer examination of the chart, it appears that shorting activities...
10$-50$ target 🎯
The recent annual numbers from Exagen Inc. show promising results, with revenues exceeding forecasts by 4.4% and statutory losses per share coming in 4.4% smaller than expected. Following these results, analysts have adjusted their earnings model, with revenue forecasts for 2024 now at US$54.2 million, reflecting a 3.1% improvement compared to...